Neurogene Inc. (NGNE) has released an update.
Neurogene Inc., a biotech firm incorporated in Delaware, has filed a Form 8-K with the SEC, indicating a current report as of April 22, 2024. The document details the company’s primary executive office location in New York and confirms their common stock is listed on The Nasdaq Global Market under the trading symbol ‘NGNE’. The company has not identified itself as an emerging growth company, suggesting a more established corporate status.
For further insights into NGNE stock, check out TipRanks’ Stock Analysis page.
